iQure Pharma .
About
What does iQure Pharma . do?
iQure Pharma is a clinical-stage biotech company developing first-in-class astrocyte-targeted therapeutics to restore glutamate balance in CNS disorders. Their lead asset, iQ-007, is an orally available EAAT2 positive allosteric modulator designed to enhance glutamate uptake and break the cycle of excitotoxicity. The company is initially focusing on epilepsy as a clinical validation path, with Parkinson's disease, migraine, and ALS as additional opportunities.
What is iQure Pharma .'s revenue?
StartupHub estimates iQure Pharma .'s annual revenue at $371K (range $211K to $1.4M, 62% confidence), based on comparable companies in the sector.
Where is iQure Pharma . headquartered?
iQure Pharma . is headquartered in Cambridge, United States.
When was iQure Pharma . founded?
iQure Pharma . was founded in 2017.
What industry does iQure Pharma . operate in?
iQure Pharma . operates in Biotech, HealthTech, Drug Discovery, Neuroscience, CNS Diseases, Astrocyte Biology.
How many employees does iQure Pharma . have?
iQure Pharma . has approximately 9 people on record.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.